This session will take a deep dive into the evolving U.S. drug pricing landscape, including the Inflation Reduction Act (IRA), the Most Favored Nation (MFN) executive order, and upcoming developments that will shape access, affordability, and innovation.
Remember Me
5/13/2024Advancing Health Equity in Pharma: Key Themes from the 2024 WOCIP Cluster Meetings
4/26/2024Pharmacoequity Takes Center Stage at Innovative WOCIP Cluster Meetings
9/20/2026NextGen - Commercial Uncovered: From Concepts to Careers
9/30/2026Career Chats - The Recruiter’s Playbook